A MAGE-A3 peptide presented by HLA-DP4 tumor cells to CD4+ cytolytic T lymphocytes

被引：0
|
作者：
Schultz, ES
Lethé, B
Van Snick, J
Chaux, P
Thielemans, K
Corthals, J
Heirman, C
Boon, T
van der Bruggen, P
机构：
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2000年 / 115卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：563 / 563
页数：1
相关论文
共 50 条
  • [1] A MAGE-A3 peptide presented by HLA-DP4 is recognized on tumor cells by CD4+ cytolytic T lymphocytes
    Schultz, ES
    Lethé, B
    Cambiaso, CL
    Van Snick, J
    Chaux, P
    Corthals, J
    Heirman, C
    Thielemans, K
    Boon, T
    van der Bruggen, P
    [J]. CANCER RESEARCH, 2000, 60 (22) : 6272 - 6275
  • [2] A MAGE-A3 peptide presented by HLA-DP4 is recognized on tumor cells by CD4+ cytolytic T lymphocytes.
    Schultz, ES
    Schuler-Thurner, B
    Lethé, B
    Cambiaso, CL
    Van Snick, J
    Chaux, P
    Corthals, J
    Heirman, C
    Thielemans, K
    Boon, T
    van der Bruggen, P
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 115 (06) : 1170 - 1170
  • [3] A MAGE-A4 peptide presented by HLA-A2 is recognized by cytolytic T lymphocytes
    Duffour, MT
    Chaux, P
    Lurquin, C
    Cornelis, G
    Boon, T
    van der Bruggen, P
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1999, 29 (10) : 3329 - 3337
  • [4] Prediction of CD4+ T cell epitopes restricted to HLA-DP4 molecules
    Busson, Marc
    Castelli, Florence A.
    Wang, Xiao-Fei
    Cohen, William M.
    Charron, Dominique
    Menez, Andre
    Maillere, B.
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 2006, 317 (1-2) : 144 - 151
  • [5] Identification of MAGE-3 epitopes presented by HLA-DR molecules to CD4+ T lymphocytes
    Chaux, P
    Vantomme, V
    Stroobant, V
    Thielemans, K
    Corthals, J
    Luiten, R
    Eggermont, AMM
    Boon, T
    van der Bruggen, P
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (05): : 767 - 777
  • [6] Lysis of human chondrosarcoma cells by cytolytic T lymphocytes recognizing a MAGE-A3 antigen presented by HLA-A1 molecules
    Bluman, Eric M.
    Coulie, Pierre G.
    Sun Xiaojuan
    Machan, Jason
    Lin, Chouzao
    Meitner, Patricia A.
    Block, Joel A.
    Terek, Richard M.
    [J]. JOURNAL OF ORTHOPAEDIC RESEARCH, 2007, 25 (05) : 678 - 684
  • [7] New MAGE-4 antigenic peptide recognized by cytolytic T lymphocytes on HLA-A1 tumor cells
    Kobayashi, T
    Lonchay, C
    Colau, D
    Demotte, N
    Boon, T
    van der Bruggen, P
    [J]. TISSUE ANTIGENS, 2003, 62 (05): : 426 - 432
  • [8] A MAGE-A4 peptide presented by HLA-B37 is recognized on human tumors by cytolytic T lymphocytes
    Zhang, Y
    Stroobant, V
    Russo, V
    Boon, T
    van der Bruggen, P
    [J]. TISSUE ANTIGENS, 2002, 60 (05): : 365 - 371
  • [9] HLA-DP4 presents an immunodominant peptide from the RSV G protein to CD4 T cells
    de Graaff, PMA
    Heidema, J
    Poelen, MC
    van Dijk, MEA
    Lukens, MV
    van Gestel, SPJ
    Reinders, J
    Rozemuller, E
    Tilanus, M
    Hoogerhout, P
    van Els, CACM
    van der Most, RG
    Kimpen, JLL
    van Bleek, GM
    [J]. VIROLOGY, 2004, 326 (02) : 220 - 230
  • [10] A polyclonal anti-vaccine CD4 T cell response detected with HLA-DP4 multimers in a melanoma patient vaccinated with MAGE-3.DP4-peptide-pulsed dendritic cells
    Zhang, Y
    Renkvist, N
    Sun, ZJ
    Schuler-Thurner, B
    Glaichenhaus, N
    Schuler, G
    Boon, T
    van der Bruggen, P
    Colau, D
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (04) : 1066 - 1075
12345